Suppr超能文献

食管鳞状细胞癌放疗后食管瘘的相关危险因素

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma.

作者信息

Hu Bing, Jia Feng, Zhou Haiyan, Zhou Tao, Zhao Qian, Chen Yiru, Li Baosheng, Huang Wei

机构信息

School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Shandong province, China.

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong province, China.

出版信息

J Cancer. 2020 Mar 31;11(12):3693-3700. doi: 10.7150/jca.39033. eCollection 2020.

Abstract

The aim of this study was to investigate risk factors for esophageal squamous cell carcinoma (ESCC) treated with radiotherapy (RT) with or without chemotherapy to guide how to reduce the occurrence of esophageal fistula (EF). 414 patients with ESCC who underwent RT with or without chemotherapy were collected in Shandong Cancer Hospital from February 2012 to June 2018 retrospectively. The clinical characters and dosimetric parameters were recorded. Univariate and multivariate logistic regression analyses were provided to determine the risk factors associated with EF. The cumulative incidences of EF were 11.1% (46/414 patients). The median follow-up period was 15.8 months (range: 0.2-82.6months). The median survival time (MST) of patients with EF was 5.3 months. In univariate analysis, age, T4 stage, N3 stage, chemotherapy regimens, re-RT, ulcerative esophageal cancer (EC), esophageal stenosis, the maximum thickness of the tumor and the length of tumor had a correlation with the prevalence of EF. In multivariable logistic regression analysis, T4 stage, N3 stage, re-RT, ulcerative EC, esophageal stenosis, the maximum thickness of the tumor was confirmed as risk factors for EF. This study revealed that T4 stage, N3 stage, re-RT, ulcerative EC, esophageal stenosis, the maximum thickness of the tumor were risk factors associated with EF. We ought to attach importance to the prevention of EF. Patients with risk factors for EF should be paid close attention.

摘要

本研究旨在探讨接受放疗(RT)联合或不联合化疗的食管鳞状细胞癌(ESCC)的危险因素,以指导如何降低食管瘘(EF)的发生。回顾性收集了2012年2月至2018年6月在山东省肿瘤医院接受RT联合或不联合化疗的414例ESCC患者。记录其临床特征和剂量学参数。采用单因素和多因素logistic回归分析确定与EF相关的危险因素。EF的累积发生率为11.1%(46/414例患者)。中位随访期为15.8个月(范围:0.2 - 82.6个月)。发生EF的患者中位生存时间(MST)为5.3个月。单因素分析中,年龄、T4期、N3期、化疗方案、再次放疗、溃疡性食管癌(EC)、食管狭窄、肿瘤最大厚度和肿瘤长度与EF的发生率相关。多因素logistic回归分析中,T4期、N3期、再次放疗、溃疡性EC、食管狭窄、肿瘤最大厚度被确认为EF的危险因素。本研究表明,T4期、N3期、再次放疗、溃疡性EC、食管狭窄、肿瘤最大厚度是与EF相关的危险因素。我们应重视EF的预防。应密切关注具有EF危险因素的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c499/7150448/c7fe87286abd/jcav11p3693g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验